EIF — MedNation AG Share Price
Last trade - 00:00- €3.44m
- €16.55m
- €37.55m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.4 | ||
| Price to Tang. Book | 0.4 | ||
| Price to Free Cashflow | 14.76 | ||
| Price to Sales | 0.09 | ||
| EV to EBITDA | 3.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.99% | ||
| Return on Equity | -20.5% | ||
| Operating Margin | 3.14% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 49.32 | 48.45 | 35.48 | 35.8 | 37.55 | n/a | n/a | -4.37% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eifelhoehen Klinik AG is a Germany-based operator of facilities for outpatient and inpatient rehabilitation, geriatric care and outpatient medical care. It operates the Eifelhoehen-Klinik Marmagen GmbH in Nettersheim-Marmagen, a specialist clinic for outpatient and inpatient internal medicine, orthopedics/traumatology, neurology; the Kaiser-Karl-Klinik GmbH in Bonn, a specialist clinic for outpatient and inpatient orthopedics, geriatrics and internal medicine, as well as the Herzpark Moenchengladbach GmbH in Moenchengladbach, a specialist clinic for outpatient and inpatient cardiac rehabilitation. In addition to that it owns a majority stake in Aatalklinik Wuennenberg GmbH and a minority stake in geriatric center Zuelpich GmbH.
Directors
- Joerg Leue CSU (58)
- Markus-Michael Kuethmann CMG
- Klaus Dirks VSU
- Lothar Lotzkat MGB
- Doris Muecke IND (60)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- October 28th, 1987
- Public Since
- April 3rd, 2012
- No. of Employees
- 470
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Frankfurt Stock Exchange
- Shares in Issue
- 3,017,424
- Address
- Graurheindorfer Strasse 137, BONN, 53117
- Web
- https://www.eifelhoehen-klinik.ag
- Phone
- +49 2289677820
- Auditors
- Kolner Wirtschaftsprufung & Steuerberatung Kurt Heller GmbH
Upcoming Events for EIF
Similar to EIF
Doccheck AG
Frankfurt Stock Exchange
Dr Wiesent Sozial gemeinnuetzige GmbH
Frankfurt Stock Exchange
Encompass Health
Frankfurt Stock Exchange
MATERNUS-Kliniken-AG
Frankfurt Stock Exchange
Synlab AG
Frankfurt Stock Exchange
FAQ
As of Today at 19:14 UTC, shares in MedNation AG are trading at €1.14. This share price information is delayed by 15 minutes.
Shares in MedNation AG last closed at €1.14 and the price had moved by -49.11% over the past 365 days. In terms of relative price strength the MedNation AG share price has underperformed the FTSE Global All Cap Index by -53.06% over the past year.
There is no consensus recommendation for this security.
MedNation AG does not currently pay a dividend.
MedNation AG does not currently pay a dividend.
MedNation AG does not currently pay a dividend.
To buy shares in MedNation AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.14, shares in MedNation AG had a market capitalisation of €3.44m.
Here are the trading details for MedNation AG:
- Country of listing: Germany
- Exchange: FRA
- Ticker Symbol: EIF
Based on an overall assessment of its quality, value and momentum MedNation AG is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MedNation AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -36.35%.
As of the last closing price of €1.14, shares in MedNation AG were trading -31.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The MedNation AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
MedNation AG's management team is headed by:
- Joerg Leue - CSU
- Markus-Michael Kuethmann - CMG
- Klaus Dirks - VSU
- Lothar Lotzkat - MGB
- Doris Muecke - IND